Mielóma multiplex: vizsgálatok itt: Norvégia
31 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisFut, nem toborozA Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05372354 · EU 2023-509384-25-00 - 1/2. fázisTaking peopleThe TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 20
- Run by
- Oslo University Hospital
See details and how to joinNCT05841550 - 2/3. fázisTaking peopleImaging multiple myeloma patients in the REMNANT study with Fluciclovine PET/CT (FLUCIPET)
- Where
- Oslo
- Életkor
- 18 év to 64 év
- People
- 50
- Run by
- Oslo University Hospital HF
See details and how to join2024-517095-38-00 - 2/3. fázisFut, nem toborozThe Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study
- Where
- Aalesund, Bergen, Bodo, Foerde, Graalum, Kristiansand S, Levanger, Lorenskog, Oslo, Stavanger, Tonsberg, Tromsoe, Trondheim
- Életkor
- 18 év to 75 év
- People
- 176 worldwide
- Run by
- Oslo University Hospital
See details and how to joinNCT04513639 · EU 2023-510215-18-00 - 2. fázisNot yet taking people in NorvégiaBispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients
- Where
- Oslo, Stavanger, Trondheim
- Életkor
- 18 év to 70 év
- People
- 50 worldwide
- Run by
- North Estonia Medical Centre
See details and how to joinNCT06505369 - No phaseTaking peopleFluciclovine PET/CT in Multiple Myeloma Patients
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 10
- Run by
- Oslo University Hospital
See details and how to joinNCT03966443